Have a personal or library account? Click to login
Development and Validation of an UHPLC Method for Ostarine Determination in Dietary Supplements Cover

Development and Validation of an UHPLC Method for Ostarine Determination in Dietary Supplements

Open Access
|Jul 2019

References

  1. 1. Thevis M, Schänzer W. Detection of SARMs in doping control analysis. Mol Cell Endocrinol. 2018; 464:34-45.10.1016/j.mce.2017.01.040
  2. 2. Solomon ZJ, Mirabal JR, Mazur DJ, Kohn TP, Lipshultz LI, Pastuszak AW. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications. Sex Med Rev. 2019; 7(1):84-94.10.1016/j.sxmr.2018.09.006
  3. 3. Miklos A, Tero-Vescan A, Vari CE, Ősz BE, Filip C, Rusz CM, Muntean DL. Selective androgen receptor modulators (SARMs) in the context of doping. Farmacia. 2018; 66(5):758-762.10.31925/farmacia.2018.5.3
  4. 4. https://www.wada-ama.org/sites/default/files/prohibited_list_2018_en.pdf
  5. 5. Hansson A, Knych H, Stanley S, Thevis M, Bondesson U, Hedeland M. Investigation of the selective androgen receptor modulators S1, S4 and S22 and their metabolites in equine plasma using high-resolution mass spectrometry. Rapid Commun Mass Spectrom. 2016; 30(7):833-842.10.1002/rcm.7512
  6. 6. Dobs AS, Boccia RV, Croot CC, Gabrail NY, Dalton JT, Hancock ML, Johnston MA, Steiner MS. Efects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol. 2013; 14:335–345.10.1016/S1470-2045(13)70055-X
  7. 7. European Pharmacopoeia 7th Edition, 2.9.5:265-266.
  8. 8. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-q-2-r1-validation-analytical-procedures-text-methodology-step-5_en.pdf
  9. 9. Cesbron N, Sydor A, Penot M, Prevost S, Le Bizec B, Dervilly-Pinel G. Analytical strategies to detect enobosarm administration in bovines. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2017; 34(4):632-640.10.1080/19440049.2016.125812227827563
  10. 10. https://cces.ca/canadian-sport-sanction-registry
  11. 11. Coss CC, Jones A, Dalton JT. Pharmacokinetic drug interactions of the selective androgen receptor modulator GTx-024(Enobosarm) with itraconazole, rifampin, probenecid, celecoxib and rosuvastatin. Invest New Drugs. 2016; 34(4):458-67.10.1007/s10637-016-0353-827105861
  12. 12. Thevis M, Lagojda A, Kuehne D, Thomas A, Dib J, Hansson A, Hedeland M, Bondesson U, Wigger T, Karst U, Schänzer W. Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing. Rapid Commun Mass Spectrom. 2015; 29(11):991-999.10.1002/rcm.718926044265
  13. 13. Van Wagoner RM, Eichner A, Bhasin S, Deuster PA, Eichner D. Chemical Composition and Labeling of Substances Marketed as Selective Androgen Receptor Modulators and Sold via the Internet. JAMA. 2017; 318(20):2004-2010.10.1001/jama.2017.17069582069629183075
DOI: https://doi.org/10.2478/amma-2019-0008 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 49 - 54
Submitted on: Feb 15, 2019
Accepted on: May 10, 2019
Published on: Jul 4, 2019
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Amalia Miklos, Amelia Tero-Vescan, Lénárd Farczádi, Daniela-Lucia Muntean, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.